Table 1 Demographic, clinical and imaging variables of the included patients.

From: The uptake pattern of 18F-sodium fluoride radioligand in brain tissue after cerebral infarction

Age, years

76 [71–81]

Female patients, n (%)

10 (50)

Hypertension, n (%)

17 (85)

Diabetes mellitus, n (%)

13 (65)

Atrial fibrillation, n (%)

6 (30)

Previous stroke history, n (%)

5 (25)

Osteoporosis, n (%)

5 (25)

Initial NIHSS, mean (SD)

4 [2.5–14.5]

Infarction size

Single lesion within 20 mm

7 (35)

Territorial lesion

11 (55)

Multiple lesions beyond single vascular territory

2 (10)

Time between index stroke and brain MRI, days

5 [3–9.5]

Time between index stroke and PET imaging, days

13.5 [9–20]

NaF uptake intensity at each organ

Infarcted lesions, maximal SUV

1.50 [0.40–3.10]

Infarcted lesions, mean SUV

1.10 [0.35–1.75]

Pons, mean SUV

0.25 [0.20–0.30]

Cerebellum, mean SUV

0.25 [0.20–0.28]

Liver, mean SUV

0.41 [0.39–0.44]

Spleen, mean SUV

0.63 [0.55–0.72]

Lumbar vertebrae, mean SUV

3.26 [2.79–3.51]

Proximal internal carotid artery, mean SUV

1.15 [1.00–1.50]

  1. NIHSS stands for National Institute of Health Stroke Scale; SD, standard deviation; PET, positron emission tomography; NaF, 18F-sodium fluoride; SUV, standardized uptake value. Variables are displayed as the number of patients (percentage) or median [25th–75th percentile] as appropriate.